{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T11:39:42Z","timestamp":1763811582502,"version":"3.41.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ecl.2024.11.001","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T13:09:28Z","timestamp":1733576968000},"page":"17-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Management of Obesity-Related Genetic Disorders"],"prefix":"10.1016","volume":"54","author":[{"given":"Romina","family":"Esbati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omid","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ecl.2024.11.001_bib1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/oby.23116","article-title":"Genetics of obesity: what we have learned over decades of research","volume":"29","author":"Bouchard","year":"2021","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.ecl.2024.11.001_bib2","first-page":"1","article-title":"Prevalence of obesity among adults and youth: United States, 2015\u20132016","volume":"288","author":"Hales","year":"2017","journal-title":"NCHS Data Brief"},{"issue":"3","key":"10.1016\/j.ecl.2024.11.001_bib4","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/ije\/dyz273","article-title":"Has the prevalence of overweight, obesity and central obesity levelled off in the United States? Trends, patterns, disparities, and future projections for the obesity epidemic","volume":"49","author":"Wang","year":"2020","journal-title":"Int J Epidemiol"},{"issue":"5368","key":"10.1016\/j.ecl.2024.11.001_bib5","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.280.5368.1374","article-title":"The search for human obesity genes","volume":"280","author":"Comuzzie","year":"1998","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.ecl.2024.11.001_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911005","article-title":"Genetics of obesity in humans: a clinical review","volume":"23","author":"Mahmoud","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.ecl.2024.11.001_bib7","doi-asserted-by":"crossref","first-page":"e2101154","DOI":"10.1002\/adbi.202101154","article-title":"Syndromic and nonsyndromic obesity: underlying genetic causes in humans","volume":"6","author":"Duis","year":"2022","journal-title":"Adv Biol (Weinh)"},{"issue":"5","key":"10.1016\/j.ecl.2024.11.001_bib8","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1530\/EJE-20-0363","article-title":"Mechanisms in endocrinology: update on treatments for patients with genetic obesity","volume":"183","author":"Poitou","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2024.11.001_bib9","series-title":"Translational cardiometabolic genomic medicine","first-page":"161","article-title":"Chapter 7 - the genetics of obesity","author":"Alonso","year":"2016"},{"issue":"10-s","key":"10.1016\/j.ecl.2024.11.001_bib10","first-page":"87","article-title":"Mendelian non-syndromic obesity","volume":"90","author":"Paolacci","year":"2019","journal-title":"Acta Biomed"},{"author":"U.S. National Library of Medicine","key":"10.1016\/j.ecl.2024.11.001_bib11"},{"issue":"2","key":"10.1016\/j.ecl.2024.11.001_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4274\/jcrpe.galenos.2023.2023-3-2","article-title":"Current treatments for patients with genetic obesity","volume":"15","author":"Faccioli","year":"2023","journal-title":"J\u00a0Clin Res Pediatr Endocrinol"},{"issue":"7","key":"10.1016\/j.ecl.2024.11.001_bib13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1517\/14712598.2015.1052789","article-title":"Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives","volume":"15","author":"Tchang","year":"2015","journal-title":"Expet Opin Biol Ther"},{"issue":"10","key":"10.1016\/j.ecl.2024.11.001_bib14","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.molmet.2017.06.015","article-title":"Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency","volume":"6","author":"Collet","year":"2017","journal-title":"Mol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2024.11.001_bib15","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.biochi.2012.03.013","article-title":"Therapeutic use of recombinant methionyl human leptin","volume":"94","author":"Vatier","year":"2012","journal-title":"Biochimie"},{"issue":"12","key":"10.1016\/j.ecl.2024.11.001_bib16","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2213-8587(20)30364-8","article-title":"Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials","volume":"8","author":"Cl\u00e9ment","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"year":"2023","series-title":"Obesity general, insurance, treatment, disease etiology and epidemiology. Metabolic and bariatric surgery exam and board review","author":"Therrien","key":"10.1016\/j.ecl.2024.11.001_bib17"},{"issue":"6","key":"10.1016\/j.ecl.2024.11.001_bib18","doi-asserted-by":"crossref","first-page":"bvac057","DOI":"10.1210\/jendso\/bvac057","article-title":"Natural history of obesity due to POMC, PCSK1, and LEPR deficiency and the impact of setmelanotide","volume":"6","author":"Wabitsch","year":"2022","journal-title":"J\u00a0Endocr Soc"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ando.2021.12.003","article-title":"Rare genetic causes of obesity: diagnosis and management in clinical care","volume":"83","author":"Dubern","year":"2022","journal-title":"Ann Endocrinol (Paris)"},{"issue":"6","key":"10.1016\/j.ecl.2024.11.001_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/obr.12531","article-title":"A\u00a0systematic review of genetic syndromes with obesity","volume":"18","author":"Kaur","year":"2017","journal-title":"Obes Rev"},{"author":"Rhythm Pharmaceuticals","key":"10.1016\/j.ecl.2024.11.001_bib21"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cmet.2018.05.008","article-title":"Patients with obesity caused by melanocortin-4 receptor mutations can Be treated with a glucagon-like peptide-1 receptor agonist","volume":"28","author":"Iepsen","year":"2018","journal-title":"Cell Metabol"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.yapd.2022.03.005","article-title":"Clinical indications for growth hormone therapy","volume":"69","author":"Danowitz","year":"2022","journal-title":"Adv Pediatr"},{"year":"2024","author":"Cerillo","key":"10.1016\/j.ecl.2024.11.001_bib24"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cell.2015.03.008","article-title":"The hunger genes: pathways to obesity","volume":"161","author":"van der Klaauw Agatha","year":"2015","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ecl.2024.11.001_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/gm157","article-title":"Genomic insights into early-onset obesity","volume":"2","author":"Choquet","year":"2010","journal-title":"Genome Med"},{"issue":"3","key":"10.1016\/j.ecl.2024.11.001_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(00)81294-5","article-title":"Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db\/db mice","volume":"84","author":"Chen","year":"1996","journal-title":"Cell"},{"issue":"6505","key":"10.1016\/j.ecl.2024.11.001_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"issue":"3740","key":"10.1016\/j.ecl.2024.11.001_bib29","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1126\/science.153.3740.1127","article-title":"Diabetes, a new mutation in the mouse","volume":"153","author":"Hummel","year":"1966","journal-title":"Science"},{"issue":"6636","key":"10.1016\/j.ecl.2024.11.001_bib30","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/43185","article-title":"Congenital leptin deficiency is associated with severe early-onset obesity in humans","volume":"387","author":"Montague","year":"1997","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ecl.2024.11.001_bib31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/oby.2006.71","article-title":"The human obesity gene map: the 2005 update","volume":"14","author":"Rankinen","year":"2006","journal-title":"Obesity"},{"key":"10.1016\/j.ecl.2024.11.001_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.med.54.101601.152403","article-title":"Genetics and pathophysiology of human obesity","volume":"54","author":"Cummings","year":"2003","journal-title":"Annu Rev Med"},{"issue":"6143","key":"10.1016\/j.ecl.2024.11.001_bib33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1126\/science.1233000","article-title":"Loss of function of the melanocortin 2 receptor accessory protein 2 is associated with mammalian obesity","volume":"341","author":"Asai","year":"2013","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ecl.2024.11.001_bib34","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cmet.2020.05.007","article-title":"Exome sequencing identifies genes and gene sets contributing to severe childhood obesity, linking PHIP variants to repressed POMC transcription","volume":"31","author":"Marenne","year":"2020","journal-title":"Cell Metab"},{"issue":"12","key":"10.1016\/j.ecl.2024.11.001_bib35","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1172\/JCI62696","article-title":"Human SH2B1 mutations are associated with maladaptive behaviors and obesity","volume":"122","author":"Doche","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"14","key":"10.1016\/j.ecl.2024.11.001_bib36","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/hmg\/10.14.1465","article-title":"Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus","volume":"10","author":"Michaud","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.ecl.2024.11.001_bib37","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cell.2018.12.009","article-title":"Human semaphorin 3 variants link melanocortin circuit development and energy balance","volume":"176","author":"van der Klaauw","year":"2019","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.ecl.2024.11.001_bib38","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jdiacomp.2017.04.026","article-title":"Genetics of non-syndromic childhood obesity and the use of high-throughput DNA sequencing technologies","volume":"31","author":"da Fonseca","year":"2017","journal-title":"J\u00a0Diabetes Complications"},{"issue":"7","key":"10.1016\/j.ecl.2024.11.001_bib39","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2310\/JIM.0b013e3181b9163d","article-title":"Leptin deficiency: clinical implications and opportunities for therapeutic interventions","volume":"57","author":"Bl\u00fcher","year":"2009","journal-title":"J\u00a0Investig Med"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMoa1406653","article-title":"Biologically inactive leptin and early-onset extreme obesity","volume":"372","author":"Wabitsch","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ecl.2024.11.001_bib41","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.pcl.2024.06.001","article-title":"The genetics of obesity","volume":"71","author":"Siddiqui","year":"2024","journal-title":"Pediatr Clin North Am"},{"issue":"2005","key":"10.1016\/j.ecl.2024.11.001_bib42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.med.56.062904.144924","article-title":"Monogenic obesity in humans","volume":"56","author":"Farooqi","year":"2005","journal-title":"Annu Rev Med"},{"issue":"8","key":"10.1016\/j.ecl.2024.11.001_bib43","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI0215693","article-title":"Beneficial effects of leptin on obesity, T\u00a0cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency","volume":"110","author":"Farooqi","year":"2002","journal-title":"J\u00a0Clin Investig"},{"issue":"16","key":"10.1016\/j.ecl.2024.11.001_bib44","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.282.16.1568","article-title":"Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial","volume":"282","author":"Heymsfield","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ecl.2024.11.001_bib45","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.gtc.2023.08.005","article-title":"Management of monogenic and syndromic obesity","volume":"52","author":"Han","year":"2023","journal-title":"Gastroenterol Clin North Am"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/EJE-19-0678","article-title":"Leptin receptor deficiency: a systematic literature review and prevalence estimation based on population genetics","volume":"182","author":"Kleinendorst","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.ecl.2024.11.001_bib47","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1210\/clinem\/dgad099","article-title":"A\u00a0national multicenter study of leptin and leptin receptor deficiency and systematic review","volume":"108","author":"Besci","year":"2023","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2024.11.001_bib48","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41591-018-0015-9","article-title":"MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency","volume":"24","author":"Cl\u00e9ment","year":"2018","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.ecl.2024.11.001_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24101892","article-title":"Current mechanistic and pharmacodynamic understanding of melanocortin-4 receptor activation","volume":"24","author":"Sharma","year":"2019","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.ecl.2024.11.001_bib50","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2213-8587(20)30364-8","article-title":"Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials","volume":"8","author":"Cl\u00e9ment","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2024.11.001_bib51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/509","article-title":"Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans","volume":"19","author":"Krude","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.ecl.2024.11.001_bib52","doi-asserted-by":"crossref","first-page":"689387","DOI":"10.3389\/fendo.2021.689387","article-title":"Two cases with an early presented proopiomelanocortin deficiency-A long-term follow-up and systematic literature review","volume":"12","author":"Gregoric","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1043-2760(99)00213-1","article-title":"Implications of proopiomelanocortin (POMC) mutations in humans: the POMC deficiency syndrome","volume":"11","author":"Krude","year":"2000","journal-title":"Trends Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2024.11.001_bib54","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa022050","article-title":"Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene","volume":"348","author":"Farooqi","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ecl.2024.11.001_bib55","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.molmed.2018.12.002","article-title":"Melanocortin-4 receptor signalling: importance for weight regulation and obesity treatment","volume":"25","author":"K\u00fchnen","year":"2019","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa0803085","article-title":"Modulation of blood pressure by central melanocortinergic pathways","volume":"360","author":"Greenfield","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ecl.2024.11.001_bib57","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.molmet.2017.06.015","article-title":"Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency","volume":"6","author":"Collet","year":"2017","journal-title":"Mol Metabol"},{"issue":"5","key":"10.1016\/j.ecl.2024.11.001_bib58","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/oby.2011.202","article-title":"Rescue of melanocortin 4 receptor (MC4R) nonsense mutations by aminoglycoside-mediated read-through","volume":"20","author":"Brumm","year":"2012","journal-title":"Obesity"},{"issue":"3","key":"10.1016\/j.ecl.2024.11.001_bib59","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng0797-303","article-title":"Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene","volume":"16","author":"Jackson","year":"1997","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.ecl.2024.11.001_bib60","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1172\/JCI200318784","article-title":"Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency","volume":"112","author":"Jackson","year":"2003","journal-title":"J\u00a0Clin Investig"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib61","first-page":"81","article-title":"A\u00a0case of prohormone convertase deficiency diagnosed with type 2 diabetes","volume":"56","author":"Karacan","year":"2021","journal-title":"Turk Arch Pediatr"},{"issue":"9","key":"10.1016\/j.ecl.2024.11.001_bib62","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1210\/jc.2007-0687","article-title":"Hyperphagia and early-onset obesity due to a novel homozygous missense mutation in prohormone convertase 1\/3","volume":"92","author":"Farooqi","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib63","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1038\/s41467-022-32509-4","article-title":"Prohormone convertase 1\/3 deficiency causes obesity due to impaired proinsulin processing","volume":"13","author":"Meier","year":"2022","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.ecl.2024.11.001_bib64","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1096\/fj.02-0831rev","article-title":"Curbing activation: proprotein convertases in homeostasis and pathology","volume":"17","author":"Taylor","year":"2003","journal-title":"Faseb J"},{"issue":"7","key":"10.1016\/j.ecl.2024.11.001_bib65","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ijo.2013.188","article-title":"Mutation screen of the SIM1 gene in pediatric patients with early-onset obesity","volume":"38","author":"Zegers","year":"2014","journal-title":"Int J Obes (Lond)"},{"issue":"6424","key":"10.1016\/j.ecl.2024.11.001_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau0629","article-title":"CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency","volume":"363","author":"Matharu","year":"2019","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ecl.2024.11.001_bib67","doi-asserted-by":"crossref","first-page":"e0177222","DOI":"10.1371\/journal.pone.0177222","article-title":"Genetic analysis of single-minded 1 gene in early-onset severely obese children and adolescents","volume":"12","author":"Stanikova","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ecl.2024.11.001_bib68","article-title":"Severe early onset obesity and hypopituitarism in a child with a novel SIM1 gene mutation","volume":"2020","author":"Gonsalves","year":"2020","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"3","key":"10.1016\/j.ecl.2024.11.001_bib69","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5152\/TurkArchPediatr.2022.21365","article-title":"Oxytocin therapy may improve eating behaviors in children with single-minded-1 gene mutation","volume":"57","author":"Korkmaz","year":"2022","journal-title":"Turk Arch Pediatr"},{"issue":"7","key":"10.1016\/j.ecl.2024.11.001_bib70","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1210\/me.2008-0067","article-title":"Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice","volume":"22","author":"Kublaoui","year":"2008","journal-title":"Mol Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib71","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13023-023-02723-4","article-title":"Burden of hyperphagia and obesity in Bardet-Biedl syndrome: a multicountry survey","volume":"18","author":"Forsythe","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.ecl.2024.11.001_bib72","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1007\/s12325-023-02443-y","article-title":"Interview-based patient- and caregiver-reported experiences of hunger and improved quality of life with setmelanotide treatment in bardet-biedl syndrome","volume":"40","author":"Ervin","year":"2023","journal-title":"Adv Ther"},{"issue":"7","key":"10.1016\/j.ecl.2024.11.001_bib73","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nm0702-643","article-title":"Elevated plasma ghrelin levels in Prader\u2013Willi syndrome","volume":"8","author":"Cummings","year":"2002","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.ecl.2024.11.001_bib74","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/edrv.22.6.0447","article-title":"Endocrine dysfunction in prader-willi syndrome: a review with special reference to GH","volume":"22","author":"Burman","year":"2001","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.ecl.2024.11.001_bib75","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1573396315666190716120925","article-title":"Prader-willi syndrome - clinical genetics, diagnosis and treatment approaches: an update","volume":"15","author":"Butler","year":"2019","journal-title":"Curr Pediatr Rev"},{"issue":"2","key":"10.1016\/j.ecl.2024.11.001_bib76","first-page":"83","article-title":"Effect of semaglutide on weight loss and glycaemic control in patients with Prader-Willi Syndrome and type 2 diabetes","volume":"71","author":"Gim\u00e9nez-Palop","year":"2024","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib77","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tem.2003.11.003","article-title":"Prader-Willi syndrome: advances in genetics, pathophysiology and treatment","volume":"15","author":"Goldstone","year":"2004","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2024.11.001_bib78","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1542\/peds.109.2.e35","article-title":"The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study","volume":"109","author":"Whitman","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.ecl.2024.11.001_bib79","series-title":"Behavioral pharmacology of neuropeptides: oxytocin","first-page":"529","article-title":"Oxytocin and prader-willi syndrome","author":"Kabasakalian","year":"2018"},{"issue":"12","key":"10.1016\/j.ecl.2024.11.001_bib80","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98333","article-title":"Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi syndrome","volume":"3","author":"Dykens","year":"2018","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.ecl.2024.11.001_bib81","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ajmg.a.38160","article-title":"Oxytocin treatment in children with Prader-Willi syndrome: a double-blind, placebo-controlled, crossover study","volume":"173","author":"Miller","year":"2017","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.ecl.2024.11.001_bib82","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2976","article-title":"The use of oxytocin to improve feeding and social skills in infants with prader-willi syndrome","volume":"139","author":"Tauber","year":"2017","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ecl.2024.11.001_bib83","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1677\/jme.1.02165","article-title":"Assessment of the anti-obesity effects of the TNP-470 analog, CKD-732","volume":"38","author":"Kim","year":"2007","journal-title":"J\u00a0Mol Endocrinol"},{"issue":"12","key":"10.1016\/j.ecl.2024.11.001_bib84","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.RES.0000132745.76882.70","article-title":"Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice","volume":"94","author":"Br\u00e5kenhielm","year":"2004","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.ecl.2024.11.001_bib85","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/dom.13021","article-title":"Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: a randomized, double-blind, placebo-controlled trial","volume":"19","author":"McCandless","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib86","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/clinem\/dgac549","article-title":"Liraglutide for weight management in children and adolescents with prader-willi syndrome and obesity","volume":"108","author":"Diene","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2024.11.001_bib87","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/cen.14583","article-title":"The effects of glucagon-like peptide (GLP)-1 receptor agonists on weight and glycaemic control in Prader-Willi syndrome: a systematic review","volume":"96","author":"Ng","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib88","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41398-019-0597-0","article-title":"Effect of topiramate on eating behaviours in Prader-Willi syndrome: TOPRADER double-blind randomised placebo-controlled study","volume":"9","author":"Consoli","year":"2019","journal-title":"Transl Psychiatry"},{"issue":"2","key":"10.1016\/j.ecl.2024.11.001_bib89","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1017\/S1461145702002833","article-title":"Topiramate attenuates self-injurious behaviour in Prader-Willi Syndrome","volume":"5","author":"Shapira","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.ecl.2024.11.001_bib90","doi-asserted-by":"crossref","first-page":"107939","DOI":"10.1016\/j.yebeh.2021.107939","article-title":"Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: a systematic review","volume":"118","author":"Steinhoff","year":"2021","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib91","doi-asserted-by":"crossref","first-page":"e0190849","DOI":"10.1371\/journal.pone.0190849","article-title":"AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: a randomized placebo-controlled trial","volume":"13","author":"Allas","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ecl.2024.11.001_bib92","doi-asserted-by":"crossref","first-page":"e2373","DOI":"10.1210\/clinem\/dgac105","article-title":"The efficacy, safety, and pharmacology of a ghrelin O-acyltransferase inhibitor for the treatment of prader-willi syndrome","volume":"107","author":"Miller","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2024.11.001_bib93","doi-asserted-by":"crossref","first-page":"e0221615","DOI":"10.1371\/journal.pone.0221615","article-title":"A\u00a0randomized pilot efficacy and safety trial of diazoxide choline controlled-release in patients with Prader-Willi syndrome","volume":"14","author":"Kimonis","year":"2019","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ecl.2024.11.001_bib94","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1210\/clinem\/dgad014","article-title":"Diazoxide choline extended-release tablet in people with prader-willi syndrome: a double-blind, placebo-controlled trial","volume":"108","author":"Miller","year":"2023","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2024.11.001_bib95","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/oby.23928","article-title":"Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label study","volume":"32","author":"Miller","year":"2024","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"10.1016\/j.ecl.2024.11.001_bib96","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/ng935","article-title":"Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome","volume":"31","author":"Mykytyn","year":"2002","journal-title":"Nat Genet"},{"issue":"suppl_1","key":"10.1016\/j.ecl.2024.11.001_bib97","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1093\/hmg\/ddh092","article-title":"The oligogenic properties of Bardet\u2013Biedl syndrome","volume":"13","author":"Katsanis","year":"2004","journal-title":"Hum Mol Genet"},{"issue":"Suppl 2","key":"10.1016\/j.ecl.2024.11.001_bib98","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/dom.15494","article-title":"Bardet-Biedl syndrome: a clinical overview focusing on diagnosis, outcomes and best-practice management","volume":"26","author":"Shoemaker","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib99","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ejhg.2012.115","article-title":"Bardet-Biedl syndrome","volume":"21","author":"Forsythe","year":"2013","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"10.1016\/j.ecl.2024.11.001_bib100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/jmg.36.6.437","article-title":"New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey","volume":"36","author":"Beales","year":"1999","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.ecl.2024.11.001_bib101","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/TCRM.S338653","article-title":"Bardet-biedl syndrome: current perspectives and clinical outlook","volume":"19","author":"Melluso","year":"2023","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib102","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13023-022-02602-4","article-title":"Quality of life improvements following one year of setmelanotide in children and adult patients with Bardet-Biedl syndrome: phase 3 trial results","volume":"18","author":"Forsythe","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"10.1016\/j.ecl.2024.11.001_bib103","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S2213-8587(22)00277-7","article-title":"Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alstr\u00f6m syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period","volume":"10","author":"Haqq","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1016\/j.ecl.2024.11.001_bib104","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/dom.14133","article-title":"Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome","volume":"22","author":"Haws","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.ecl.2024.11.001_bib105","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MED.0000000000000798","article-title":"Setmelanotide: a promising advancement for pediatric patients with rare forms of genetic obesity","volume":"30","author":"Trapp","year":"2023","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"17","key":"10.1016\/j.ecl.2024.11.001_bib106","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJMoa2103329","article-title":"Obesity-associated GNAS mutations and the melanocortin pathway","volume":"385","author":"Mendes de Oliveira","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ecl.2024.11.001_bib107","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.cmet.2009.05.004","article-title":"Central nervous system imprinting of the G protein G(s)alpha and its role in metabolic regulation","volume":"9","author":"Chen","year":"2009","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.ecl.2024.11.001_bib108","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000508985","article-title":"Recommendations for diagnosis and treatment of pseudohypoparathyroidism and related disorders: an updated practical tool for physicians and patients","volume":"93","author":"Mantovani","year":"2020","journal-title":"Horm Res Paediatr"},{"issue":"9","key":"10.1016\/j.ecl.2024.11.001_bib109","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa0801119","article-title":"Brain-derived neurotrophic factor and obesity in the WAGR syndrome","volume":"359","author":"Han","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ajmg.10013","article-title":"Third case of WAGR syndrome with severe obesity and constitutional deletion of chromosome (11)(p12p14)","volume":"107","author":"G\u00fcl","year":"2002","journal-title":"Am J Med Genet"},{"issue":"6","key":"10.1016\/j.ecl.2024.11.001_bib111","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archinte.165.6.675","article-title":"New Alstr\u00f6m syndrome phenotypes based on the evaluation of 182 cases","volume":"165","author":"Marshall","year":"2005","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.ecl.2024.11.001_bib112","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1136\/jmg.2005.039867","article-title":"Mutational spectrum of COH1 and clinical heterogeneity in Cohen syndrome","volume":"43","author":"Seifert","year":"2006","journal-title":"J\u00a0Med Genet"},{"issue":"2","key":"10.1016\/j.ecl.2024.11.001_bib113","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0022-3476(73)80493-7","article-title":"A\u00a0new syndrome with hypotonia, obesity, mental deficiency, and facial, oral, ocular, and limb anomalies","volume":"83","author":"Cohen","year":"1973","journal-title":"J\u00a0Pediatr"},{"issue":"7","key":"10.1016\/j.ecl.2024.11.001_bib114","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1210\/jc.2018-00258","article-title":"Melanocortin 4 receptor pathway dysfunction in obesity: patient stratification aimed at MC4R agonist treatment","volume":"103","author":"Ayers","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2024.11.001_bib115","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1210\/er.2006-0040","article-title":"Genetics of obesity in humans","volume":"27","author":"Farooqi","year":"2006","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.ecl.2024.11.001_bib116","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2016-2573","article-title":"Pediatric obesity\u2014assessment, treatment, and prevention: an endocrine society clinical practice guideline","volume":"102","author":"Styne","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2024.11.001_bib117","doi-asserted-by":"crossref","first-page":"972174","DOI":"10.3389\/fendo.2022.972174","article-title":"Clinical, genetic, and epidemiological survey of Polish children and adolescents with severe obesity: a study protocol of the Polish-German study project on severe early-onset obesity","volume":"13","author":"Mierzwa","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"10.1016\/j.ecl.2024.11.001_bib118","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI0215693","article-title":"Beneficial effects of leptin on obesity, T\u00a0cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency","volume":"110","author":"Farooqi","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.ecl.2024.11.001_bib119","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s11695-021-05869-x","article-title":"Long-term weight outcome after bariatric surgery in patients with melanocortin-4 receptor gene variants: a case-control study of 105 patients","volume":"32","author":"Cooiman","year":"2022","journal-title":"Obes Surg"},{"key":"10.1016\/j.ecl.2024.11.001_bib120","unstructured":"Morales J. and Simonetti J., Genetic mutations and weight loss post-bariatric surgery [Poster presentation]. The Obesity Society Annual Meeting (TOS), Dallas (TX), 2023."},{"issue":"4","key":"10.1016\/j.ecl.2024.11.001_bib121","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1046\/j.1469-0705.2001.00253.x","article-title":"Prenatal diagnosis of Bardet-Biedl syndrome by targeted second-trimester sonography","volume":"17","author":"Dar","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ecl.2024.11.001_bib122","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/uog.1086","article-title":"Antenatal renal sonographic anomalies and postnatal follow-up of renal involvement in Bardet-Biedl syndrome","volume":"24","author":"Cassart","year":"2004","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852924000914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852924000914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T13:31:31Z","timestamp":1750253491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852924000914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":121,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0889852924000914"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2024.11.001","relation":{},"ISSN":["0889-8529"],"issn-type":[{"type":"print","value":"0889-8529"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Obesity-Related Genetic Disorders","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2024.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}